Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada.
Ethan Miller | Getty Images
Charitable trust stock Abbott Labs (ABT) reported fourth-quarter earnings before the opening bell on Wednesday. On the top line, sales of $11.5 billion (+7.7% YoY organic) exceeded the $10.64 billion consensus. On the bottom line, adjusted diluted earnings of $1.32 per share (-9.0% YoY) outpaced the $1.19 per share consensus.